根据 3 位华尔街分析师的预测,Sinopharm Group Co. Ltd. 的收入预期范围从 $299.23B 到 $279.28B
Sinopharm Group Co. Ltd. 的盈利质量评分是多少?
Sinopharm Group Co. Ltd. 的盈利质量评分为 /。该评分基于盈利能力、增长、现金生成与资本分配以及杠杆四个维度。
Sinopharm Group Co. Ltd. 何时发布财报?
Sinopharm Group Co. Ltd. 的下一份财报预计在 2026-07-26 发布
Sinopharm Group Co. Ltd. 的预期收益是多少?
根据华尔街分析师的预测,Sinopharm Group Co. Ltd. 的预期收益为 $
Sinopharm Group Co. Ltd. 是否超出收益预期?
Sinopharm Group Co. Ltd. 最近的收益为 $, 预期。
关键数据
前收盘价
$11.73
开盘价
$11.54
当日区间
$11.48 - $11.54
52周范围
$11.4 - $14.87
交易量
584
平均成交量
66.5K
股息收益率
--
每股收益(TTM)
1.68
市值
$3.0B
什么是 Sinopharm Group Co. Ltd.?
Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. The firm operates its business through four segments. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services to domestic and foreign pharmaceutical and health product manufacturers and other suppliers. The Device Distribution segment distributes medical devices to customers. The Pharmaceutical Retail Business segment owns a network of retail pharmacies that are directly operated or franchised. The Other Business segment is engaged in the manufacture and sale of pharmaceuticals, chemical reagents and laboratory supplies.